Distinct clinicopathological features in metanephric adenoma harboring BRAF mutation.
Caliò A, Eble JN, Hes O, Martignoni G, Harari SE, Williamson SR, Brunelli M, Osunkoya AO, Wang L, Comperat E, Lopez-Beltran A, Wang M, Zhang S, Curless KL, Post KM, Chang HY, Luchini C, Baldrige LA, MacLennan GT, Montironi R, Grignon DJ, Cheng L.
Caliò A, et al. Among authors: post km.
Oncotarget. 2016 Aug 8;8(33):54096-54105. doi: 10.18632/oncotarget.11117. eCollection 2017 Aug 15.
Oncotarget. 2016.
PMID: 28903326
Free PMC article.